Screening of potential α-glucosidase inhibitors from astragalus membranaceus by affinity ultrafiltration screening coupled with UPLC-ESI-Orbitrap-MS method

Hong-Ping Wang,Zhao-Zhou Lin,Chen Zhao,Qiong Yin,Jun Jia
DOI: https://doi.org/10.1080/10286020.2024.2366007
2024-06-15
Journal of Asian Natural Products Research
Abstract:Astragalus membranaceus is a traditional Chinese medicine with multiple pharmacological activities. Modern pharmacological research has found that Astragalus membranaceus extract has an inhibitory effect on α-glucosidase, however, which component can inhibit the activity of α-glucosidase and its degree of inhibition are unknown. To address this issue, this study used affinity ultrafiltration screening combined with UPLC-ESI-Orbitrap-MS technology to screen α-glucosidase inhibitors in Astragalus membranaceus . Using affinity ultrafiltration technology, we obtained the active components, and using UPLC-ESI-Orbitrap-MS technology, we quickly analyzed and identified them. As a result, a total of 8 ingredients were selected as α-glucosidase inhibitors.
pharmacology & pharmacy,chemistry, medicinal, applied,plant sciences
What problem does this paper attempt to address?